Vaccination with autologous myeloblasts admixed with GM-K562 cells in patients with advanced MDS or AML after allogeneic HSCT

Autor: Ho, Vincent T. 1, 2, *, Kim, Haesook T. 3, Bavli, Natalie 1, 2, Mihm, Martin 4, 5, Pozdnyakova, Olga 6, Piesche, Matthias 1, 2, 7, Daley, Heather 1, 2, Reynolds, Carol 1, 2, Souders, Nicholas C. 1, 2, Cutler, Corey 1, 2, Koreth, John 1, 2, Alyea, Edwin P. 1, 2, Antin, Joseph H. 1, 2, Ritz, Jerome 1, 2, Dranoff, Glenn 1, 2, Soiffer, Robert J. 1, 2
Zdroj: In Blood Advances 14 November 2017 1(24):2269-2279
Databáze: ScienceDirect